17-BETA-CARBOXANILIDES OF 4-AZA-5-ALPHA-ANDROSTAN-3-ONES AS 5-ALPHA-REDUCTASE INHIBITORS
申请人:Merck & Co., Inc.
公开号:EP0663924B1
公开(公告)日:2001-02-14
17$g(b)-CARBOXANILIDES OF 4-AZA-5$g(a)-ANDROSTAN-3-ONES AS 5$g(a)-REDUCTASE INHIBITORS
申请人:MERCK & CO. INC.
公开号:EP0663924A1
公开(公告)日:1995-07-26
US5693810A
申请人:——
公开号:US5693810A
公开(公告)日:1997-12-02
[EN] 17 beta -CARBOXANILIDES OF 4-AZA-5 alpha -ANDROSTAN-3-ONES AS 5 alpha -REDUCTASE INHIBITORS<br/>[FR] 17 beta -CARBOXANILIDES DE 4-AZA-5 alpha -ANDROSTAN-3-ONES UTILISES COMME INHIBITEURS DE 5 alpha -REDUCTASE
申请人:MERCK & CO., INC.
公开号:WO1994007861A1
公开(公告)日:1994-04-14
(EN) Described are new 17$g(b)-carboxanilides of 4-aza-5$g(a)-androstan-3-ones and related compounds and the use of such compounds as 5$g(a)-reductase inhibitors for treatment of benign prostatic hyperplasia and other hyperandrogenetic related disorders.(FR) L'invention se rapporte à de nouveaux 17$g(b)-carboxanilides de 4-aza-5$g(a)-androstan-3-ones, à des composés apparentés, ainsi qu'à l'utilisation de tels composés comme inhibiteurs de 5$g(a)-réductase pour le traitement de l'hypertrophie de la prostate et d'autres affections hyperandrogènes associées.